摩根大通：2026年重点关注四大投资主题

Core Viewpoint - Morgan Stanley maintains a constructive outlook on the CSI 300 index, projecting a target level of 5200 points by the end of 2026, driven by four major investment themes [1] Group 1: Investment Themes - The execution of "anti-involution" policies is expected to accelerate post the National People's Congress in March 2024, benefiting the net profit margin and return on equity of CSI 300 constituents [1] - Growth in global AI infrastructure capital expenditure is anticipated to favor Chinese suppliers, with more domestic stocks and AI monetization targets expected to benefit despite being in crowded growth sectors [1] - A favorable global macroeconomic environment, particularly in fiscal and monetary policy easing in 2026, will support overseas sales for listed companies [1] - The K-shaped recovery in consumption will benefit both low-end and luxury goods [1] Group 2: Potential Risks - There are three potential downside risks: a possible downward adjustment in Q4 earnings expectations for the CSI 300, particularly in the technology and healthcare sectors; the ongoing push for "high-quality development" may suppress excessive speculation and further pressure mid-range consumption; and despite a trade truce between China and the US, new confrontations may arise amid increasing regional tensions [2] Group 3: Stock Selection - Morgan Stanley has identified IT and healthcare A-shares that can capitalize on China's innovation opportunities, expecting a shift from value stocks to growth stocks by early 2026 [2] - The team has also selected leading A-share companies in sectors such as automotive, battery materials, lithium, photovoltaics, cement, chemicals, coal, steel, dairy, pork, liquor, and logistics that are poised to benefit from the "anti-involution" trend, indicating a shift from price/scale competition to quality competition over a decade [2]